(PharmaNewsWire.Com, July 13, 2017 ) Psoriasis is non communicable inflammatory skin condition that alter the life cycle of skin cells by speeding up the growth of cells on the surface of the skin. Rapid development of cells produces thick, silver scales, and makes the skin red, dry, flaky, and itchy. Currently, no permanent cure is available for the disease, however preventative measures can be adopted to slow down the growth of skin cells on the surface of the skin. Psoriasis can be treated either with pharmaceuticals or biopharmaceuticals therapies through topical and systemic process. These medications administered either by applying on the skin, or consumed orally, or through injections specifically block parts of immune system process by specifically targeting Tumor Necrosis Factor (TNF), Phosphodiesterase Type 4 (PDE4), Interleukin, among others.
The growth of Psoriasis Drugs market is majorly driven by factors such as rising healthcare expenditure, introduction of novel and more efficient drug, and expected entry of late-stage products. The key restraints of the market are high cost involved in drug development, patent expiry of brand name drugs, and low efficacy of the product. Additionally, Psoriasis is not very prevalent in Asia-Pacific reason further restricting the growth for the product.
Asia-Pacific Psoriasis Drugs Market is segmented on the basis of Drug Type, Route of Administration, and target. Based on Drug Type, the market is classified into Pharmaceuticals and Biopharmaceuticals. On the basis of Route of Administration, the market is classified into Topical and Systemic (Oral, Intravenous, and Others). On the basis of Target, the market is classified into Tumour Necrosis Factor, Phosphodiesterase Type 4, Interleukin, and Others
The Asia-Pacific market is geographically segmented into China, India, Japan, South Korea and Australia.
The major companies dominating the Asia-Pacific Psoriasis Drugs Market are Johnson & Johnson (USA), Novartis International AG (Switzerland), Pfizer Inc (USA), Merck and Co. Inc (USA), Celgene Corporation (USA), Janssen Biotech Inc (USA), Stiefel Laboratories Inc (USA), Takeda Pharmaceutical Company Limited (Japan), Amgen (USA), and AbbVie (USA).
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: